Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 9
2004 11
2005 12
2006 22
2007 14
2008 17
2009 30
2010 33
2011 37
2012 36
2013 30
2014 55
2015 68
2016 60
2017 60
2018 76
2019 78
2020 121
2021 130
2022 123
2023 124
2024 49

Text availability

Article attribute

Article type

Publication date

Search Results

1,053 results

Results by year

Filters applied: . Clear all
Page 1
Long COVID and its Management.
Koc HC, Xiao J, Liu W, Li Y, Chen G. Koc HC, et al. Among authors: xiao j. Int J Biol Sci. 2022 Jul 11;18(12):4768-4780. doi: 10.7150/ijbs.75056. eCollection 2022. Int J Biol Sci. 2022. PMID: 35874958 Free PMC article. Review.
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
Beck LA, Deleuran M, Bissonnette R, de Bruin-Weller M, Galus R, Nakahara T, Seo SJ, Khokhar FA, Vakil J, Xiao J, Marco AR, Levit NA, O'Malley JT, Shabbir A. Beck LA, et al. Among authors: xiao j. Am J Clin Dermatol. 2022 May;23(3):393-408. doi: 10.1007/s40257-022-00685-0. Epub 2022 May 3. Am J Clin Dermatol. 2022. PMID: 35503163 Free PMC article.
Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment.
Jian Y, Chang L, Shi MX, Sun Y, Chu XX, Xue H, Huang WR, Shen XL, Ma J, Jia GR, Feng YQ, Xi ZF, Zhao YH, Ma YP, Xiao J, Ma GY, Wang QM, Bao L, Dong YJ, Zhou HB, Sun CY, Su GH, Yan Y, Qimuge SY, Su LP, Sun JN, Tian WW, Sun XL, Ing HM, Gao D, Chen WM, Li J, Gao W. Jian Y, et al. Among authors: xiao j. Blood Adv. 2023 Dec 26;7(24):7581-7584. doi: 10.1182/bloodadvances.2023011428. Blood Adv. 2023. PMID: 37922425 Free PMC article. No abstract available.
Recent Advances in Constructing Higher-Order DNA Structures.
Wang J, Wang DX, Liu B, Jing X, Chen DY, Tang AN, Cui YX, Kong DM. Wang J, et al. Among authors: jing x. Chem Asian J. 2022 Mar 1;17(5):e202101315. doi: 10.1002/asia.202101315. Epub 2022 Jan 22. Chem Asian J. 2022. PMID: 34989140 Review.
Review immune response of targeting CD39 in cancer.
Liu Y, Li Z, Zhao X, Xiao J, Bi J, Li XY, Chen G, Lu L. Liu Y, et al. Among authors: xiao j. Biomark Res. 2023 Jun 7;11(1):63. doi: 10.1186/s40364-023-00500-w. Biomark Res. 2023. PMID: 37287049 Free PMC article. Review.
Advances in phosphoproteomics and its application to COPD.
Zeng X, Lan Y, Xiao J, Hu L, Tan L, Liang M, Wang X, Lu S, Peng T, Long F. Zeng X, et al. Among authors: xiao j. Expert Rev Proteomics. 2022 Jul-Dec;19(7-12):311-324. doi: 10.1080/14789450.2023.2176756. Epub 2023 Feb 13. Expert Rev Proteomics. 2022. PMID: 36730079 Review.
1,053 results